Cheng Liu

Company: Eureka Therapeutics

Job title: President & Chief Executive Officer

Seminars:

A Safer and More Efficacious Cell Therapy Construct for Solid Tumors 11:30 am

Showcasing a head-to-head comparison “ARTEMIS vs CAR Technology” in T-cell therapy against solid tumors Targeting Glypican 3 (GPC3) in advanced hepatocellular carcinoma (HCC) Designing ARTEMIS Antibody TCR (AbTCR) T-cells to overcome major hurdles in treating solid tumors Infiltrating solid tumors in an immunosuppressive microenvironment Demonstrating superior safety and efficacy of ARTEMIS T cellsRead more

day: Conference Day Two

Panel Discussion: Translating Complex Cell Therapies into Clinical Success for Solid Tumors 12:00 pm

Sharing insights and challenges from the forefront of developing complex cell therapies for solid tumors Discussing strategies to enhance cell therapy efficacy and overcome the complex tumor microenvironment Analyzing clinical data to inform future development and optimization of complex cell therapy approachesRead more

day: Conference Day Two